Want to create an interactive transcript for this episode?
Podcast: CME
Episode: Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
Description:
Faculty: Jennifer R. Brown, MD, PhD
Faculty: William Mencia, MD, FACEHP
This activity explores treatment sequencing strategies for chronic lymphocytic leukemia (CLL) following frontline therapy failure based on prior therapies, mechanisms of resistance, and minimal residual disease status. Dr. Jennifer Brown discusses how distinguishing between resistance and intolerance to BTK and BCL2 inhibitors informs second-line treatment decisions. The conversation highlights the role of measurable residual disease (MRD) in guiding therapy duration, biomarker reassessment, and shared decision-making based on patient preferences and clinical risk factors.